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Abstract
AIM: To identify specific colonoscopic findings in pa-
tients with ulcerative colitis (UC) complicated by cyto-
megalovirus (CMV) infection. 
METHODS: Among UC patients who were hospitalized 
due to exacerbation of symptoms, colonoscopic findings 
were compared between 15 CMV-positive patients and 
58 CMV-negative patients. CMV infection was deter-
mined by blood test for CMV antigenemia. Five aspects 
of mucosal changes were analyzed (loss of vascular 
pattern, erythema, mucosal edema, easy bleeding, and 
mucinous exudates) as well as five aspects of ulcerative 
change (wide mucosal defect, punched-out ulceration, 
longitudinal ulceration, irregular ulceration, and cobble-
stone-like appearance). Sensitivity, specificity, positive 
predictive value, and negative predictive value of each 
finding for CMV positivity were determined. 
RESULTS: The sensitivity of irregular ulceration for 
positive CMV was 100%. The specificity of wide muco-
sal defect was 95%. Punched-out ulceration and lon-
gitudinal ulceration exhibited relatively high sensitivity 
and specificity (more than 70% for each).
CONCLUSION: Specific colonoscopic findings in pa-
tients with UC complicated by CMV infection were 
identified. These findings may facilitate the early diag-
nosis of CMV infection in UC patients.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Ulcerative colitis (UC) is a worldwide, chronic, idiopathic, 
inflammatory disease of  the rectal and colonic mucosa. 
Patients with UC suffer from abdominal pain, diarrhea 
with blood, tenesmus, and urgency to defecate. In Japan, 
the number of  patients with UC was reported to be only 
4400 in 1980. However, the number has increased sharply 
in recent years, and was estimated to be approximately 
100 000 persons in 2008. This number is thought to 
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increase by about 5000 persons each year. 
Cytomegalovirus (CMV) belongs to the herpes virus 
group and is prevalent in adults. Primary CMV infection in 
immunocompetent people is usually asymptomatic, but the 
virus remains in the white blood cells throughout the life 
of  the host. Clinically significant diseases occur in patients 
with suppressed cellular immunity, especially in transplant 
patients, acquired immunodeficiency syndrome (AIDS) 
patients, and patients undergoing chemotherapy. The 
disease is usually the result of  reactivation of  the latent 
virus rather than reinfection with the virus. Significant 
CMV disease may occur in various organs such as the 
retina, lung, and gastrointestinal tract, and the target organ 
may be related to the etiology of  immunosuppression. 
In the gastrointestinal tract, CMV disease can occur in all 
locations from the mouth to the rectum, and usually forms 
ulcers in the mucosa, often accompanied by hemorrhage[1]. 
CMV infection has been described as a cause of  
relapse of  inflammatory bowel disease[2-5]. In particular, 
CMV infection was observed in UC patients, especially 
those receiving high-dose corticosteroid therapy[4-7]. 
Moreover, CMV infection can exacerbate the disease[2-5]. 
Retrospective studies of  UC patients have found CMV 
infection in 5%-21% of  surgically resected specimens[2-4,8]. 
Steroid resistance is also reported to be one of  the 
characteristics of  CMV infection in UC[6,8]. In recent 
prospective studies, 25%-81% of  patients with steroid-
refractory UC were found to harbor the virus[5-7]. Thus, 
CMV infection in UC patients can have a severe clinical 
course and may cause death if  appropriate treatment is 
not given. However, with the development of  ganciclovir 
(GCV) therapy, outcomes have greatly improved[9]. 
Therefore, it is necessary to make an early diagnosis of  
CMV infection in UC patients. Although several different 
methods have been developed to examine CMV infection, 
such as histology including immunohistochemistry[10,11], 
serology[10-12], CMV culture[13,14], polymerase chain reaction 
(PCR) for CMV genome[14-16], and CMV antigenemia[14-16], 
it is necessary, with regard to clinical aspects, to suspect 
that UC patients also have CMV infection. In general, the 
symptoms of  UC alone are not sufficient to distinguish 
exacerbation of  UC due to CMV infection from exacer-
bation of  UC unrelated to CMV infection. Specific 
colonoscopic findings for CMV infection, if  any, may 
facilitate the early diagnosis of  CMV infection. 
Several reports have examined colonoscopic findings 
related to CMV infection. However, most of  these reports 
focused on colonoscopic findings in patients with AIDS or 
in transplant patients[17,18]. The spectrum of  colonoscopic 
findings in those patients was variable and ranged from 
patchy erythema, exudates, and microerosions to diffusely 
edematous mucosa, multiple mucosal erosions, deep 
ulcers and pseudotumors[1,13,17-22]. In contrast, colonoscopic 
findings of  UC complicated by CMV infection have rarely 
been reported. Only a few studies have described findings 
without confirmation by statistical analysis[20]. 
Accordingly, the aim of  this study was to identify 
specific colonoscopic findings in patients with UC comp­
licated by CMV infection. To achieve this, we compared 
colonoscopic findings in CMV-positive and -negative 
patients, and determined the sensitivity, specificity, positive 
predictive value (PPV) and negative predictive value (NPV) 
of  each specific finding for CMV positivity.
MATERIALS AND METHODS
Patients
This study was a retrospective analysis of  medical charts 
and endoscopic images of  UC patients. From January 
1999 to August 2007, a total of  200 UC patients were 
hospitalized in Okayama University Hospital with 
exacerbation of  UC symptoms. We began to routinely 
examine CMV antigenemia in these patients from 2003. 
Therefore, of  these 200 patients, 111 did not receive 
a blood test for CMV antigenemia at admission, and 
13 did not receive an endoscopic examination. Thus, a 
total of  76 patients who received both a blood test for 
CMV antigenemia and an endoscopic examination at 
admission were analyzed in this study. This study was 
approved by the institutional review board of  Okayama 
University Graduate School of  Medicine, Dentistry, and 
Pharmaceutical Sciences.
The diseases in these patients were pancolitis or left-
sided colitis with moderate or severe activity, based on 
clinical, endoscopic, and histological findings according to 
established criteria[23-25]. Medical charts provided clinical 
parameters including demographic data such as age, 
gender, and duration of  the disease, as well as disease 
status such as severity of  disease, extent of  disease, and 
medications.
Diagnosis of CMV infection
Diagnosis of  CMV infection was determined by CMV 
antigenemia, which was examined by detecting CMV pp65 
antigen in peripheral blood leukocytes using the direct 
immunoperoxidase technique with horseradish peroxidase-
conjugated Fab’ fragment of  human monoclonal antibody 
(C7-HRP) and immunofluorescence staining with 
monoclonal antibodies C10/11. The examinations were 
performed in the laboratory of  SRL Inc. (Tokyo, Japan). 
We defined a patient as CMV­positive when one or more 
positive cells of  either C7-HRP or C10/11 were detected 
in more than 10 000 leukocytes (the minimum number of  
positive cells). 
Endoscopic findings
Endoscopic findings were evaluated by examining 
recorded colonoscopic images and reports. Two aspects 
of  colonic changes were assessed: mucosal change 
and ulcerative change. Mucosal change was evaluated 
according to the following five features: easy bleeding, 
loss of  vascular pattern, mucosal edema, erythema, and 
mucinous exudates. Each item was expressed as “severe” 
or “not severe” according to the severity of  each change. 
Easy bleeding was defined as bleeding from the fragile 
membrane due to slight contact of  the endoscope. Loss 
of  vascular pattern was loss of  visible vessels under the 
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membrane, generally seen during colonoscopy. Mucosal 
edema was defined as thick and swollen membrane 
which pooled fluid. Erythema was red coloration of  
the membrane composed of  dilated veins. Mucinous 
exudates were exudates composed of  blood and pus.
For ulcerative changes, we determined whether or 
not the following forms of  ulceration were observed: 
wide mucosal defect, punched-out ulceration, longitudi-
nal ulceration, irregular ulceration, and cobblestone-like 
appearance. A wide mucosal defect was a wide area of  
this defect with a longitudinal and/or transverse spread, 
indicating that more than one-fourth of  the mucosa in 
the endoscopic field was defective (Figure 1A). Punched­
out ulceration formed an almost round shape of  ulcer-
ation with clear demarcation (Figure 1B). Longitudinal 
ulceration had a longitudinal spread along the lumen of  
the colon (Figure 1C). Irregular ulceration was defined 
as ulceration with an irregular pattern and a branched 
shape (Figure 1D). Cobblestone-like appearance was an 
aggregate of  elevated lesions as a result of  the changes 
in the membrane, which looked like half-spheres of  sub-
pedunculated polyps with multiple ulceration as seen in 
Crohn’s disease (Figure 1E). Each endoscopic image was 
evaluated by two (Suzuki H and Kato J) of  the authors. 
If  there were any disagreements in these evaluations, 
a third reviewer (Hiraoka S) made the final evaluation. 
At the time of  interpretation of  the images, the CMV 
antigenemia results were blinded to interpreters. The rate 
of  disagreements between the two authors was less than 
5%.
Statistical analysis
Of the clinical characteristics, the χ2 test and Fisher’s exact 
test were used to compare two discrete variables. The 
significance of  differences for continuous variables was 
assessed by the Mann-Whitney U-test. Of  the endoscopic 
findings, we calculated sensitivity, specificity, PPV, and 
NPV for CMV positivity. In addition, odds ratios (OR) 
with 95% CI were determined by a univariate logistic 
regression model. The results were considered statistically 
significant when P values were less than 0.05. Statistical 
analysis of  the data was carried out with SAS software 
version 9.2 (SAS Institute, Cary, NC, USA). 
RESULTS
Patients
A total of  76 patients received a blood test for CMV an-
tigenemia and a colonoscopy at admission. Of  these, 18 
patients were positive for CMV antigenemia, while the 
remaining 58 patients were negative. Of  the 18 CMV-
positive patients, symptoms in 3 patients were relatively 
mild, and those patients entered remission without anti-
viral therapy. The remaining 15 patients required GCV 
therapy for a period of  two weeks, together with dose 
reduction of  corticosteroids. As a consequence of  these 
treatments, all patients entered remission. Therefore, a 
comparative analysis was performed on 15 CMV-positive 
patients vs 58 CMV-negative patients. 
The clinical characteristics of  these 73 patients are 
shown in Table 1. There were no significant differences 
in clinical characteristics such as gender, age, duration 
of  disease, disease activity, extent of  disease, use of  
corticosteroids, and use of  immunomodulators (azathio-
prine or mercaptopurine) between CMV-positive and 
-negative patients. It is noteworthy that all the CMV-
positive patients received corticosteroid therapy. 
Specific endoscopic findings of UC with CMV infection
To identify specific endoscopic findings of  UC comp-
licated by CMV infection, five aspects of  mucosal changes 
(loss of  vascular pattern, erythema, mucosal edema, easy 
bleeding, and mucinous exudates) as well as five aspects 
of  ulcerative change (wide mucosal defect, punched-out 
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Figure 1  Typical endo­
scopic findings of ulce­
rative changes. A: Wide 
mucosal defect; B: Punched-
out ulceration; C: Longitudinal 
ulceration; D: Irregular ulce-
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ulceration, longitudinal ulceration, irregular ulceration, 
and cobblestone-like appearance) were analyzed. The 
sensitivity, specificity, PPV and NPV of  each finding for 
CMV positivity were determined. In addition, univariate 
logistic regression analyses were performed to determine 
the OR and 95% CI of  each finding (Table 2). 
Of  the 5 mucosal changes, loss of  vascular pattern, 
edema, and erythema exhibited relatively high sensitivity 
for CMV positivity (87%, 80%, and 87%, respectively), 
whereas easy bleeding and mucinous exudates exhibited 
high specificity (88% and 81%, respectively). Of  the 5 
ulcerative changes, irregular ulceration showed 100% 
sensitivity, but relatively low specificity (41%). Wide 
mucosal defect and cobblestone-like appearance showed 
relatively high specificity (95% and 83%, respectively), 
but low sensitivity. The sensitivity and specificity of  
punched-out ulceration and longitudinal ulceration were 
both relatively high (punched-out ulceration, sensitivity 
80%, specificity 74%, longitudinal ulceration sensitivity 
73%, specificity 78%, respectively). 
Univariate logistic regression analysis revealed that 
severe easy bleeding was seen more frequently in CMV-
positive patients than in CMV-negative patients (OR 
= 2.20, 95% CI: 1.14-4.28). Wide mucosal defect (OR 
= 4.58, 95% CI: 2.21-10.73), punched-out ulceration 
(OR = 3.39, 95% CI: 1.78-7.46), longitudinal ulceration 
(OR = 3.09, 95% CI: 1.66-6.26), and cobblestone-like 
appearance (OR = 2.05, 95% CI: 1.11-3.82) were more 
frequently observed in CMV-positive patients than in 
CMV-negative patients.
DISCUSSION
Colonoscopy is generally performed in UC patients 
who undergo flare-ups. Direct observation of  the 
colon provides detailed information on the disease 
status and is useful for comprehending the severity of  
disease, and thus it is an important tool for formulating 
treatments. However, although CMV infection can cause 
poor prognosis in UC patients (i.e. a high chance of  
colectomy), reports on the specific colonoscopic findings 
of  UC with CMV infection are scarce. Therefore, in 
this study we analyzed the colonoscopic findings of  UC 
patients with and without CMV infection, and showed 
that there were specific findings that predicted CMV 
infection in UC patients. 
There have been reports on the endoscopic findings 
of  CMV colitis in AIDS or transplant patients. These 
findings include patchy erythema, exudates, microero-
sions, diffusely edematous mucosa, multiple mucosal 
erosions, or deep ulcers and pseudotumors[1,13,17-22]. In 
UC patients, however, the findings would be more com-
plicated, because inflammatory changes due to UC itself  
in colonic mucosa exists prior to CMV infection. There-
fore, in previous studies, no specific endoscopic findings 
were observed in UC patients with concomitant CMV 
infection[6,26]. In contrast, in our study, specific colono-
scopic findings of  UC with CMV infection were ob-
served; the sensitivity of  irregular ulceration was 100%, 
the specificity of  wide mucosal defect was 95%, and 
the sensitivity and specificity of  punched­out ulceration 
and longitudinal ulceration were both greater than 70%. 
Therefore, in cases where these colonoscopic findings 
are seen in UC patients, examination to confirm CMV 
infection should be performed as soon as possible.
It is known that UC patients with CMV infection, 
especially those who are compromised by corticosteroid 
therapy, experience severe symptoms. These patients 
are likely to undergo colectomy, and CMV infection 
has been confirmed in 4.6%­25% of  patients who have 
undergone colectomy[2,3,7,8]. Recently the efficacy of  
GCV in CMV infection has become widely recognized. 
Pfau et al[9] considers GCV a beneficial treatment that 
significantly decreases the mortality rate and the need 
for surgery. Wada et al[6] found that GCV was effective 
in 8 (67%) of  12 patients with CMV infection. They 
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Table 1  Characteristics of enrolled patients
CMV positive (n  = 15) CMV negative (n  = 58) P  value
Gender
    Male   8 (53) 26 (45) 0.55
    Female   7 (47) 32 (55)
Age (yr), median (range)      42 (17-65)      34 (14-81) 0.72
Duration of disease (d), median (range)        528 (15-9358)       1503 (5-10 791) 0.40
Disease activity at admission
    Moderate   9 (60) 41 (71) 0.43
    Severe   6 (40) 17 (29)
Extent of disease
    Pancolitis 12 (80) 42 (72) 0.74
    Left-sided   3 (20) 16 (28)
Current use of corticosteroids
    Yes   15 (100) 47 (81) 0.11
    No 0 (0) 11 (19)
Current use of immunomodulators (AZA/6-MP)
    Yes 1 (7)   7 (12) > 0.99
    No 14 (93) 51 (88)
Data are numbers with percentages in parentheses or medians with ranges in parentheses. CMV: Cytomegalovirus.
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also reported that steroid withdrawal improved steroid-
resistant UC. Matsuoka et al[27] reported that most CMV 
reactivation-positive patients responded to conventional 
immunosuppressive therapies, however, high values of  
CMV antigenemia may be an indicator for antiviral treat-
ment regardless of  histology. Thus, treatment for UC 
patients with CMV infection should be different from 
that for UC patients without CMV infection. Therefore, 
our findings that predict CMV infection should be useful 
in therapeutic decision-making for UC patients.
In addition, there are several studies on the prophylac-
tic/pre-emptive therapy of  CMV diseases in patients with 
solid organ transplants, hematopoietic stem cell trans-
plants, and human immunodeficiency virus disease[27-29]. 
These reports suggested the importance of  early detection 
of  CMV reactivation and early administration of  anti-viral 
drugs before the development of  CMV disease. Although 
no concept of  prophylactic therapy has been established 
for UC patients, early detection and early antiviral therapy 
may be considered because of  the high rate of  colectomy 
in these patients. In this context, early prediction of  CMV 
infection in UC patients by colonoscopy would seem 
helpful in clinical settings. 
There are several methods of  detecting CMV infec-
tion: histology including immunohistochemistry[10,11], 
serology[10-12], CMV culture[13,14], PCR for CMV ge-
nome[14-16], and CMV antigenemia[14-16]. Each method has 
advantages and disadvantages for the precise diagnosis 
of  CMV infection. For example, histological examina-
tion is a relatively easy method, but the sensitivity is not 
so high (10%-87%)[10-12]. Meanwhile, PCR for the CMV 
genome is very sensitive, but the false-positive rate is 
relatively high. In our analysis, CMV antigenemia was 
adopted to detect CMV infection, because examination 
of  CMV antigenemia is relatively sensitive (60%-100%) 
and easy to measure within a short period[10,14,16,30]. In 
addition, this method has been used for monitoring 
CMV infection in heart transplant recipients, and for 
the early diagnosis of  CMV infection in renal transplant 
recipients[29]. Moreover, it has been reported that posi-
tive or negative results of  CMV antigenemia are a good 
indication for antiviral therapy[28,31]. In fact, in our study, 
15 (83%) of  18 patients who were positive for CMV 
antigenemia required antiviral therapy with GCV, and all 
of  these patients entered remission without colectomy. 
In general, immunohistochemistry is considered the 
gold standard in the diagnosis of  CMV infection. In our 
cohort, however, among 6 patients with positive CMV 
antigenemia whose biopsy specimens were immunos-
tained with antibody for CMV, only 3 exhibited positive 
immunostaining. In addition, although we performed 
immunostaining in 16 of  58 patients with negative CMV 
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Table 2  The correlations between CMV positivity and endoscopic findings
CMV positive 
(n  = 15)
CMV negative 





PPV (%)  NPV (%) Odds ratio 95% CI P  value
Easy bleeding
    Severe   6 (40)   7 (12)   40 88 46   85 2.20 1.14-4.28 0.02
    Not severe   9 (60) 51 (88)
Loss of the vascular pattern
    Severe 13 (87) 37 (64)   87 36 26   91 1.92 0.95-5.01 0.11
    Not severe   2 (13) 21 (36)
Edema
    Severe 12 (80) 33 (57)   80 43 27   89 1.74 0.92-3.79 0.11
    Not severe   3 (20) 25 (43)
Erythema
    Severe 13 (87) 39 (67)   87 33 25   90 1.78 0.88-4.64 0.15
    Not severe   2 (13) 19 (33)
Mucinous exudates
    Severe   4 (27) 11 (19)   27 81 27   81 1.25 0.61-2.36 0.51
    Not severe 11 (73) 47 (81)
Wide mucosal defect
    ≥ 1/4 field   8 (53) 3 (5)   53 95 72   89 4.58 2.21-10.73   0.0001
    < 1/4 field   7 (47) 55 (95)
Punched-out ulceration
    Yes 12 (80) 15 (26)   80 74 44   93 3.39 1.78-7.46   0.0006
    No   3 (20) 43 (74)
Longitudinal ulceration
    Yes 11 (73) 13 (22)   73 78 46   92 3.09 1.66-6.26   0.0007
    No   4 (27) 45 (78)
Irregular ulceration
    Yes   15 (100) 34 (59) 100 41 31 100 ND ND ND
    No 0 (0) 24 (41)
Cobblestone-like appearance
    Yes   7 (47) 10 (17)   47 83 41   86 2.05 1.11-3.82 0.02
    No   8 (53) 48 (83)
PPV: Positive predictive value; NPV: Negative predictive value; 95% CI: 95% confidence interval; ND: Not determined.
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antigenemia, none of  them exhibited positive staining. 
Therefore, the use of  CMV antigenemia for CMV detec-
tion in this study was appropriate.
Our study has several limitations. First, CMV infec-
tion was determined by CMV antigenemia alone. As 
described above, there are several methods to detect 
CMV infection. A combination of  these methods may 
have increased the CMV detection rate. Second, of  the 
18 CMV antigenemia-positive patients, 15 patients who 
were given GCV were analyzed in our study. However, 
it is not certain that all 15 patients really required GCV 
therapy. Some of  these patients may have improved 
without GCV similar to the remaining 3 patients. Third, 
this is a retrospective study that relied on the examina-
tion of  recorded colonoscopic images. Therefore, bias 
due to patient collection and missed recording of  colo-
noscopic findings may inevitably exist. Finally, this is a 
relatively small scale study in Japan, and it is possible that 
the results might differ in patients of  other ethnicities 
from other parts of  the world.
In the case of  a severe flare­up of  UC, the possibil-
ity of  a concurrent CMV infection causing or worsening 
colitis should be considered, especially when patients are 
on immunosuppressive medications that may make them 
more susceptible to this viral infection. The prognosis of  
UC cases with CMV infection is considered poor. Thus, 
CMV infection should be closely investigated in such 
cases, and anti-CMV treatment (GCV) should be given 
immediately to reduce the rate of  colectomy. The specific 
colonoscopic findings of  patients with UC complicated by 
CMV infection observed in this study may facilitate early 
diagnosis and treatment of  CMV infection.
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